BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 35220887)

  • 1.
    Zhang Y; Zhang L; Zheng S; Li M; Xu C; Jia D; Qi Y; Hou T; Wang L; Wang B; Li A; Chen S; Si J; Zhuo W
    Gut Microbes; 2022; 14(1):2038852. PubMed ID: 35220887
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Martin-Gallausiaux C; Salesse L; Garcia-Weber D; Marinelli L; Beguet-Crespel F; Brochard V; Le Gléau C; Jamet A; Doré J; Blottière HM; Arrieumerlou C; Lapaque N
    Gut Microbes; 2024; 16(1):2295384. PubMed ID: 38126163
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Xu C; Fan L; Lin Y; Shen W; Qi Y; Zhang Y; Chen Z; Wang L; Long Y; Hou T; Si J; Chen S
    Gut Microbes; 2021; 13(1):1980347. PubMed ID: 34632963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fusobacterium nucleatum Increases Proliferation of Colorectal Cancer Cells and Tumor Development in Mice by Activating Toll-Like Receptor 4 Signaling to Nuclear Factor-κB, and Up-regulating Expression of MicroRNA-21.
    Yang Y; Weng W; Peng J; Hong L; Yang L; Toiyama Y; Gao R; Liu M; Yin M; Pan C; Li H; Guo B; Zhu Q; Wei Q; Moyer MP; Wang P; Cai S; Goel A; Qin H; Ma Y
    Gastroenterology; 2017 Mar; 152(4):851-866.e24. PubMed ID: 27876571
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Yin H; Miao Z; Wang L; Su B; Liu C; Jin Y; Wu B; Han H; Yuan X
    Aging (Albany NY); 2022 Feb; 14(4):1941-1958. PubMed ID: 35212644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fusobacterium nucleatum reduces METTL3-mediated m
    Chen S; Zhang L; Li M; Zhang Y; Sun M; Wang L; Lin J; Cui Y; Chen Q; Jin C; Li X; Wang B; Chen H; Zhou T; Wang L; Hsu CH; Zhuo W
    Nat Commun; 2022 Mar; 13(1):1248. PubMed ID: 35273176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fusobacterium nucleatum induces oxaliplatin resistance by inhibiting ferroptosis through E-cadherin/β-catenin/GPX4 axis in colorectal cancer.
    Li B; Wei Z; Wang Z; Xu F; Yang J; Lin B; Chen Y; Wenren H; Wu L; Guo X; Liu Y; Wei Y
    Free Radic Biol Med; 2024 Aug; 220():125-138. PubMed ID: 38657754
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Chen S; Su T; Zhang Y; Lee A; He J; Ge Q; Wang L; Si J; Zhuo W; Wang L
    Gut Microbes; 2020 May; 11(3):511-525. PubMed ID: 31910722
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Wu QL; Fang XT; Wan XX; Ding QY; Zhang YJ; Ji L; Lou YL; Li X
    World J Gastroenterol; 2024 Apr; 30(14):2018-2037. PubMed ID: 38681125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspirin Modulation of the Colorectal Cancer-Associated Microbe Fusobacterium nucleatum.
    Brennan CA; Nakatsu G; Gallini Comeau CA; Drew DA; Glickman JN; Schoen RE; Chan AT; Garrett WS
    mBio; 2021 Apr; 12(2):. PubMed ID: 33824205
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Chen Y; Chen Y; Zhang J; Cao P; Su W; Deng Y; Zhan N; Fu X; Huang Y; Dong W
    Theranostics; 2020; 10(1):323-339. PubMed ID: 31903123
    [No Abstract]   [Full Text] [Related]  

  • 12. Iron accelerates Fusobacterium nucleatum-induced CCL8 expression in macrophages and is associated with colorectal cancer progression.
    Yamane T; Kanamori Y; Sawayama H; Yano H; Nita A; Ohta Y; Hinokuma H; Maeda A; Iwai A; Matsumoto T; Shimoda M; Niimura M; Usuki S; Yasuda-Yoshihara N; Niwa M; Baba Y; Ishimoto T; Komohara Y; Sawa T; Hirayama T; Baba H; Moroishi T
    JCI Insight; 2022 Nov; 7(21):. PubMed ID: 36136589
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Engevik MA; Danhof HA; Ruan W; Engevik AC; Chang-Graham AL; Engevik KA; Shi Z; Zhao Y; Brand CK; Krystofiak ES; Venable S; Liu X; Hirschi KD; Hyser JM; Spinler JK; Britton RA; Versalovic J
    mBio; 2021 Mar; 12(2):. PubMed ID: 33653893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fusobacterium nucleatum upregulates MMP7 to promote metastasis-related characteristics of colorectal cancer cell via activating MAPK(JNK)-AP1 axis.
    Ou S; Chen H; Wang H; Ye J; Liu H; Tao Y; Ran S; Mu X; Liu F; Zhu S; Luo K; Guan Z; Jin Y; Huang R; Song Y; Liu SL
    J Transl Med; 2023 Oct; 21(1):704. PubMed ID: 37814323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fusobacterium nucleatum promotes chemoresistance to 5-fluorouracil by upregulation of BIRC3 expression in colorectal cancer.
    Zhang S; Yang Y; Weng W; Guo B; Cai G; Ma Y; Cai S
    J Exp Clin Cancer Res; 2019 Jan; 38(1):14. PubMed ID: 30630498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fusobacterium Nucleatum Is a Risk Factor for Metastatic Colorectal Cancer.
    Chen WD; Zhang X; Zhang YP; Yue CB; Wang YL; Pan HW; Zhang YL; Liu H; Zhang Y
    Curr Med Sci; 2022 Jun; 42(3):538-547. PubMed ID: 35678912
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Hu L; Liu Y; Kong X; Wu R; Peng Q; Zhang Y; Zhou L; Duan L
    Front Immunol; 2021; 12():658681. PubMed ID: 34093546
    [No Abstract]   [Full Text] [Related]  

  • 18. Metformin elicits antitumour effect by modulation of the gut microbiota and rescues Fusobacterium nucleatum-induced colorectal tumourigenesis.
    Huang X; Hong X; Wang J; Sun T; Yu T; Yu Y; Fang J; Xiong H
    EBioMedicine; 2020 Nov; 61():103037. PubMed ID: 33039709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Fusobacterium nucleatum with immunity and molecular alterations in colorectal cancer.
    Nosho K; Sukawa Y; Adachi Y; Ito M; Mitsuhashi K; Kurihara H; Kanno S; Yamamoto I; Ishigami K; Igarashi H; Maruyama R; Imai K; Yamamoto H; Shinomura Y
    World J Gastroenterol; 2016 Jan; 22(2):557-66. PubMed ID: 26811607
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Hong J; Guo F; Lu SY; Shen C; Ma D; Zhang X; Xie Y; Yan T; Yu T; Sun T; Qian Y; Zhong M; Chen J; Peng Y; Wang C; Zhou X; Liu J; Liu Q; Ma X; Chen YX; Chen H; Fang JY
    Gut; 2021 Nov; 70(11):2123-2137. PubMed ID: 33318144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.